Von Willebrand factor (VWF) is a multimeric glycoprotein present in circulating blood and in secretory granules of endothelial cells and platelets. VWF is sensitive to hydrodynamic shear stress that promotes conformational changes, rendering it able to interact with subendothelial proteins and platelets, thus promoting primary haemostasis. Likewise, the binding of the glycopeptide antibiotic ristocetin to VWF triggers hemostatically relevant conformational transitions. These changes reveal both the interaction site for platelet receptor GpIbα and the Tyr1605-Met1606 peptide bond, which is cleaved by the regulatory metalloprotease ADAMTS-13.
INTRODUCTION
Vascular damage is followed rapidly by adhesion and firm attachment of platelets at the site of endothelial injury. At sites of high blood flow, von Willebrand factor (VWF) plays a central role in this process [1, 2] , as it primarily modulates platelet-subendothelium interaction by linking the platelet receptor GpIb/IX/V to the extracellular matrix [3, 4] . In fact, when immobilized on subendothelial matrix, VWF forms a reactive surface capable of capturing platelets from flowing blood [5, 6] . High shear stress causes micro-and macro-conformational changes of VWF from a globular state to a stretched chain [7] . VWF derives from a complex gene (180 kb, 52 exons), and is synthesized as pre-pro-VWF, including a 22-residue signal peptide and a 741-residue propeptide.
VWF undergoes extensive post-translational processing, glycosylation, and assembly in the endoplasmic reticulum, Golgi and post-Golgi and consists of ∼250 kDa monomeric subunits, which form disulfide-linked multimers of 500 to 20000 kDa. Each VWF subunit contains 2050 amino acids made up of conserved modular domains in the order D8-D3-A1-A2-A3-D4-B1-B2-B3-C1-C2 ( [2] ). Interaction of the platelet GpIbα receptor with the A1-domain of immobilized VWF [8] results in an initial adhesion, characterized by a continuous surface translocation of the platelets [9] . This process ultimately leads to a stable platelet adhesion through interaction with the platelet collagen receptors GpVI and GpIa/2A [10] , activation of the platelet Gp2B/I2A receptor complex [3] and finally to platelet aggregation.
The interaction between VWF and GpIbα does not occur under static conditions and needs a pre-activation of soluble VWF. This process consists of a conformational change of VWF molecules, that expose within the A1 domain the binding site for GpIbα. This mechanism is triggered either by mechanical forces, such as high shear rate (>5000 sec -1 ) found in the arterial circulation, or by chemical potential generated by interaction with external surfaces and chemicals/snake venoms [5, [11] [12] [13] [14] [15] . Finally, natural mutations causing type 2B von Willebrand disease (VWD 2B) such as the Arg1306Trp or Arg1341Trp [6] , are also able to stabilize a A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT 4 conformational state that is prone to the interaction with the platelet receptor even under very low shear conditions and causes platelet clumping in the systemic circulation [6, 16] .
Recently, it has been demonstrated that VWF multimers undergo a dramatic shape change as a function of shear rate [13, 17] , which is responsible for the formation of VWF fibers, that are organized as a spider-web like structures. This network may represent an ideal anchor to capture flowing platelets during the process of primary haemostasis [13] . Notably, that VWF could self associate and aggregate under high shear stress was known from previous studies. For instance, a shear-dependent self-association of VWF in suspension was demonstrated in a cone-plate viscometer [5] . These studies showed that in all cases the aggregation and web-formation process is essentially linked to the mechanical force generated by shear. In this study, we investigated the formation of VWF macro-aggregates induced by ristocetin. The latter is a polyphenol glycopeptide synthesized by the actinomycete Nocardia lurida, that was shown to have potent antibacterial activity. The introduction of this antibiotic in clinical practice, caused frequent drug-induced thrombocytopenia, which was demonstrated to be associated with extensive intravascular platelet agglutination [18, 19] . Later on in vitro studies discovered that this molecule is able to specifically bind to the A1-domain of VWF, eliciting a conformational change responsible for VWF binding to platelet GpIbα [17] . This property is currently used in the clinical diagnostics of VWD, to detect both defective (type 2A and 2M) and hyper-reactive (type 2B) VWF mutants. The investigation is aimed at assessing the ability of VWF to undergo a self association process induced by chemical potential of this allosteric effector, even in the absence of hydrodynamic shear stress and any protein adsorbing surface.
MATERIAL AND METHODS

VWF purification and characterization
VWF was purified from fresh frozen plasma of type A-or B-specific blood group of healthy volunteers by glycine salt precipitation [20] . It was gel filtered on a Sephacryl-S500 3x100 column equilibrated with Hepes 10 mM, NaCl 150 mM, pH 7.5 connected to an FPLC apparatus (Pharmacia) operating at a flow rate of 1 ml/min. Eluate was collected in 5 ml-fractions, following the procedure described elsewhere [21] . Electrophoresis and immunoblotting of VWF in 1-5% agarose gels containing sodium dodecyl sulfate (SDS-agarose) was performed as previously described [22] . Final protein concentration was determined by UV absorbance at 280 nm on a double beam Varian model Cary 2200 spectrophotometer (PaloAlto, CA), using an extinction coefficients ε (0.1%) = 0.846, calculated on the basis of the amino acid composition of the VWF monomer. In addition, VWF concentration was also measured by an immunoturbidometric method, using an automatic coagulometer (Top, Instrumentation Laboratory, Milano, Italy) and a commercially available assay (Hemosyl VWF antigen, Instrumentation Laboratory, Milano, Italy), which show that a concentration of 10 µg/ml VWF, measured by spectrophotometric method, correspond to about 1 U/ml. A modification of the standard protocol for sodium dodecyl sulfate (SDS-agarose) gel was used [22] . After the electrophoresis and immunoblotting of VWF in 1.5% agarose gels, the detection was performed using a chemiluminescence procedure (Amersham Life Science). A sheet of Kodak BioMax MR film (Eastman Kodak Company, New Haven, CT, USA) was placed over the membrane and exposed for times varying from 10 seconds to 2 minutes.
Ristocetin (Helena Laboratories Corp., Beaumont, TX) standard solution (16 mg/ml) was prepared and freed of sulphate ions, as previously detailed [23] . The molarity of the ristocetin 
VWF aggregation kinetics induced by ristocetin
Light Scattering Theory
The outlines of the theory related to light scattering techniques is described in biophysics textbooks [24] . We shall only briefly describe some basic aspects.
Back Scattering measurements
Dynamic Light Scattering (DLS) measurements on protein solutions were carried out with a Zetasizer Nano S (Malvern Instruments, Malvern, U.K.) equipped with a 4 mW He-Ne laser (633 nm). Measurements were performed at 25°C, at an angle of 173° from the incident beam. Peak intensity analyses were used to determine the average hydrodynamic diameters (Z-average diameter) of the scattering particles. Polydispersity index was obtained by a cumulant analysis of the intensity autocorrelation function using version 5.0 of the Nano software [25] . In each measurement the sample was placed in a 45 µl quartz Suprasil cuvette of 10 mm light path (Hellma Italia, Milan, Italy). After the sample was allowed to equilibrate to 25°C, ristocetin was added and the aggregate formation and evolution was monitored for 24 h. Each measurement was the average of a different number of subruns automatically determined, each being averaged for 10 s. Control measurements were made on solvent and on different ristocetin or VWF concentrations (ranging from 0.01 and 4 mg/ml and 0.01 and 0.9 µM, respectively). Kinetics of the self-aggregation mechanism induced by ristocetin was studied monitoring the Z-average diameter and scattered intensity as a function of time. Time zero was defined as a VWF solution in the measurement cell before ristocetin was added.
Both scattered intensity and Z-average diameter vs time plots showed a multiphase process.
Scattered intensity rapidly increases, reaches a plateau and finally decays (i.e. an asymmetrical bellshaped curve). On the other hand, the Z-average diameter time-dependent profile shows, after an exponential increase (phase 1), a sigmoidal shape. Finally, the asymptote is reached, but significant fluctuation in the Z-average diameter values are observed. The process is well described by the
following phenomenological equation, that has been used to fit the experimental data according to the least square minimization procedure, by means of Microsoft Excel software.
:
is the VWF hydrodynamic radius just before the Ristocetin addition and directions. Several authors [26, 27] have developed theoretical models to determine the size, molecular weight, mass-length ratio of biological macromolecules and systems. Such models were able to describe a reasonable molecular structure when applied to soluble VWF molecules, but completely failed in the analysis of the aggregated system.
RESULTS
In figure 1 As soon as the final plateau is reached for the Z-average diameter, its value is insensitive to five fold dilution with a buffer solution containing the same final ristocetin concentration, or to the same dilution with a buffer solution alone (data not shown). This fact demonstrates that the aggregation process is irreversible.
Alternatively, the polymerization-aggregation process can be followed by means of changes of the wavelength (λ) dependence of turbidity (τ) over time. Different theoretical models were described for simple molecule shapes (spheres, rods, random coils [24] ). In case of rod-like particles (expected for VWF multimers) with diameters that are small compared with the wavelength, τ should vary as λ -3 and should go to zero as λ → ∞ [28] . When the fiber diameter grows relative to λ, the plot is no longer linear, but the quantity cτ -1 λ -3 , where c is the concentration, changes linearly with λ -2 , and the intercept of the plot gives the mass-length ratio of the fibers [27] .
This behaviour can be partially observed with soluble VWF molecules (R H ranging from 35 to190 nm, see fig. 2c ). In the 700-600 nm interval τ/τ max vs λ -3 plot is linear (see figure 6 -closed circle) but does not extrapolate to the origin (probably due to the presence of particles of different shape arising from the intrinsic multimeric pattern of the protein); for λ ranging from 320 to 600 nm the plot is no longer linear. After addition of ristocetin, the plot completely deviates from the theoretical model and evolves over time progressively deviating from the initial shape, so that the interference at lower wavelength can be only partially ascribed to ristocetin spectroscopic properties. In figure 6 we 
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DISCUSSION
VWF does not normally interact with platelets in the bloodstream, but exposed vascular subendothelium enables VWF to interact with the platelet glycoprotein Ib-IX-V complex (GP Ib-IX-V). Ristocetin is a poly-phenol molecule, which interacts with the A1 domain of VWF and also promotes interaction of VWF with GPIb-IX-V, thus providing a model for changes in VWF conformation that may occur in vivo. The molecular mapping of the ristocetin binding site in the A1 domain of VWF is not known in detail, although site-directed mutagenesis showed some of the residues directly or indirectly involved in binding of the antibiotic (Lys534, Arg571, Lys572, Glu596, Glu613, Arg616, Glu626, and Lys642 of the A1 domain, (numbering based on the A1 primary sequence) [14] ). Likewise, the mechanism responsible for the induced conformational changes is not known. Recent X-ray diffraction studies of the GpIb-A1 crystal complex revealed that the α1-β2 loop of A1 serves as a conformational switch. In fact, both an open α1-β2 isomer, which allows faster dissociation of GpIbα-A1, and an extended isomer, which favours tight association, were observed in the complex containing A1 with a wild-type and type 2B von Willebrand Disease (VWD) mutation, respectively [29] . Binding of ristocetin to VWF A1 domain, inducing the interaction of the protein with the N-terminal domain of platelet GpIb, supports the process of primary haemostasis. The latter arises also from the VWF ability to interact with subendothelial matrix proteins, such as collagen. Previous studies showed that the transformation of multimeric plasma-derived VWF into a widespread immobilized network depends on several physical and biochemical factors as a critical protein concentration, induced shear stress, and an appropriate anchoring surface, mainly represented in vivo by matrix proteins [13] .
In the present study, a multiphase process of VWF conformational transitions after interaction with ristocetin is described for the first time and the kinetic aspect of the reaction are shown. The molecular transition induced in vivo by shear stress or promoted in vitro by ristocetin is a part of a more complex process composed by different steps. The rapid interaction with ristocetin "activates" VWF molecules triggering an increase in the their apparent dimension, as detectable by
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This process reflects an initial formation of activated clusters of VWF multimers. The second part of the kinetics is characterized by a slower rate constant and by a non exponential time dependence of the increase in the size of the cluster, thus suggesting the occurrence of a reaction-limited regime, culminating with a physical phase transition that is detectable by eye-inspection. We were able to find highly reproducible experimental conditions so that each step of the process can be described.
The observed multiphase scattering signal is strongly dominated by the aggregating VWF molecules, even if ristocetin is likely to dimerize at the concentration used in the present study [30] .
Ristocetin was previously reported to trigger flocculation of several proteins, included fibrinogen and VWF [30] . However this process is a non-specific aggregation following a simple linear kinetic. Moreover, in a previous study, the amount of flocculated proteins was evaluated after centrifugation (i.e. after disrupting possible growing supramolecular structures) [30] . We were able to confirm, by light scattering measures, that human fibrinogen flocculation occurs also at low ristocetin concentration (<1 mg/ml -data not shown). On the other hand, the complex kinetic profile observed with VWF, triggered only at high (>1 mg/ml) ristocetin concentration, suggests for a specific binding of molecules and an ordered polymerization process. Finally, the peculiar behaviour of scattered intensity and turbidity could be attributed to destructive interferences by large particles or physical state sol-gel transition as also evident by visual inspection of samples at higher VWF concentrations.
Self-aggregation of VWF was already observed using high hydrodynamic shear stress (>30 dyn/cm 2 ); in this case the "physical" stretching triggers the molecular activation thus leading to conformational changes promoting the potential adhesion of the protein. Beside inducing the binding to GpIb or to collagen surface, "activated" VWF was demonstrated to self-aggregate [13, 31] . However, the data on molecular dimensions of VWF were obtained on the protein studied as a function of shear rate (up to >5000 sec -1 ) in a viscometer and successively transferred in a light
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ACCEPTED MANUSCRIPT 15 scattering apparatus, thus disrupting growing supra-molecular structures. Likewise, a previous study using biotinylated VWF, immobilized on a plastic surface, showed that VWF is able to reversibly self-agregate under static condition [12] . Both the regions 1-1365 and 1366-2050 are able to inhibit this VWF-VWF interaction [12] . However it must be emphasized that this self-aggregation was obtained under static condition but linked to VWF adhesion to synthetic surface that elicits VWF conformational changes. The present study demonstrates, for the first time, the ability of a chemical potential (i.e. ristocetin binding) to induce in solution under static conditions VWF self-aggregation and network development in suspension, likely mimicking the physiological mechanism, triggered by physical forces, involved in controlling platelet adhesion rates in circulation.
On the basis of the present findings, we propose that the conformational changes induced by ristocetin binding disrupts the multiple domain interactions present in the native VWF structure.
Hence, upon stabilization of the extended conformation, the swapped domains of a VWF multimer can interact with another domain of a different multimer. In other words, the non-covalent intramolecular interaction between domains in the same VWF multimer chain, may be broken and restored between different multimer chains by identical intermolecular contacts [32] . This process can contribute to progressive aggregation culminating in a phase transition with the formation of the micro-gel network.
This mechanism, in vivo, should optimize the formation of a spider-web like network, which anchors circulating platelets through binding of the GpIb-IX-V membrane complex. Moreover, we can hypothesize that the dimensions of VWF multimers affect the efficiency and thus the rate of this network's formation. The proposed mechanism may play a relevant role in all the clinical conditions characterized by particular abundance of ultra-large VWF multimers such as thrombotic microangiopathies; in fact, a pathological deposition of these VWF aggregates in microcirculation, may contribute to the thrombo-hemorrhagic syndromes occurring in these clinical settings. distribution as function of molecule diameter. A peak for ristocetin (○) at 2.37 nm (PdI = 0.268) and
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Figure legend
for VWF (continuous line) at 75.0 nm (PdI = 0.297) was determined. However, ristocetin peak can be resolved only at concentration >0.5 mg/ml so that scattering from VWF strongly dominates the total scattered light from solution of the two molecules at any concentration combination used in the present study. 
